TNFRSF13B and systemic lupus erythematosus: Given the importance of B cells in the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis (LN), in addition to B-cell depletion therapies (BCDTs), targeting the BAFF/APRIL/TACI pathways represents another B-cell-targeting therapeutic strategy for autoimmune diseases.